VERACYTE, INC. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Veracyte, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2024.
  • Veracyte, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 77.5M shares, a 6.16% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 77.5M +4.5M +6.16% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 76.7M +4.1M +5.65% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 76.4M +4.04M +5.58% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 73.3M +1.31M +1.81% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 73M +1.25M +1.75% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 72.6M +1.08M +1.52% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 72.4M +950K +1.33% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 72M +836K +1.18% Dec 31, 2022 10-K 2024-02-29
Q3 2022 71.7M +709K +1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 71.6M +4.09M +6.06% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 71.4M +4.2M +6.24% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 71.1M +12.9M +22.2% Dec 31, 2021 10-K 2023-03-01
Q3 2021 71M +13.2M +22.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 67.5M +17M +33.8% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 67.2M +17.2M +34.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 58.2M +8.58M +17.3% Dec 31, 2020 10-K 2022-02-28
Q3 2020 57.8M +8.99M +18.4% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 50.4M +2.19M +4.54% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 50M +8.49M +20.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 49.6M +8.76M +21.4% Dec 31, 2019 10-K 2021-02-22
Q3 2019 48.8M +8.29M +20.4% Sep 30, 2019 10-Q 2019-10-22
Q2 2019 48.3M +13.8M +40.1% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 41.5M +7.18M +20.9% Mar 31, 2019 10-Q 2019-04-30
Q4 2018 40.9M +7.1M +21% Dec 31, 2018 10-K 2020-02-25
Q3 2018 40.5M +6.56M +19.3% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 34.4M +550K +1.62% Jun 30, 2018 10-Q 2018-07-23
Q1 2018 34.3M +459K +1.36% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 33.8M 0 0% Dec 31, 2017 10-K 2019-02-25
Q3 2017 34M +6.04M +21.6% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 33.9M +6.03M +21.6% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 33.9M +6.01M +21.6% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 33.8M +6.08M +22% Dec 31, 2016 10-K 2018-02-27
Q3 2016 27.9M +283K +1.02% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 27.9M +268K +0.97% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 27.9M +5.31M +23.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 27.7M +5.16M +22.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 27.7M +5.17M +23% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 27.6M +6.15M +28.7% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 22.6M +1.39M +6.56% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 22.5M +1.38M +6.53% Dec 31, 2014 10-K 2016-03-14
Q3 2014 22.5M +21.5M +2166% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 21.4M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 21.2M Mar 31, 2014 10-Q 2014-05-09
Q4 2013 21.1M +20.5M +3067% Dec 31, 2013 10-K 2015-03-25
Q3 2013 993K Sep 30, 2013 10-Q 2013-11-25
Q4 2012 668K Dec 31, 2012 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.